CD4 and cancer: This activation is distinct from the CD4+ T-cell-mediated humoral immunity to cancer-derived antigens, a typical mechanism of PLE; however, it may cause clinical symptoms similar to those of PLE, such as memory loss, and emotional and behavioral changes.